Alnylam Pharmaceuticals
ALNY
#640
Rank
โ‚ฌ29.91 B
Marketcap
231,91ย โ‚ฌ
Share price
-0.59%
Change (1 day)
36.56%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ2.64 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has โ‚ฌ2.64 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Alnylam Pharmaceuticals - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚ฌ2.20 B7.97%
2022-12-31โ‚ฌ2.04 B-4.96%
2021-12-31โ‚ฌ2.15 B41.12%
2020-12-31โ‚ฌ1.52 B11.13%
2019-12-31โ‚ฌ1.37 B44.7%
2018-12-31โ‚ฌ0.94 B-32.74%
2017-12-31โ‚ฌ1.40 B136.45%
2016-12-31โ‚ฌ0.59 B-39.7%
2015-12-31โ‚ฌ0.98 B72.51%
2014-12-31โ‚ฌ0.57 B221.75%
2013-12-31โ‚ฌ0.17 B91.76%
2012-12-31โ‚ฌ92.84 M-17.64%
2011-12-31โ‚ฌ0.11 B-35.68%
2010-12-31โ‚ฌ0.17 B-10.76%
2009-12-31โ‚ฌ0.19 B-36.2%
2008-12-31โ‚ฌ0.30 B15.27%
2007-12-31โ‚ฌ0.26 B62.2%
2006-12-31โ‚ฌ0.16 B143.8%
2005-12-31โ‚ฌ67.53 M98.96%
2004-12-31โ‚ฌ33.94 M84.26%
2003-12-31โ‚ฌ18.42 M24.42%
2002-12-31โ‚ฌ14.8 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ0.64 B-75.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.31 B 252.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.13 B-56.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.38 B-85.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ82.98 M-96.86%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ13.32 B 404.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ6.92 B 162.00%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ3.15 B 19.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel